Sana Biotechnology, Inc.SANANASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank79
3Y CAGR-28.4%
5Y CAGR-9.0%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-28.4%/yr
Quarterly compound
5Y CAGR
-9.0%/yr
Recent deceleration
Percentile
P79
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 18.48% |
| Q3 2025 | -0.54% |
| Q2 2025 | -9.95% |
| Q1 2025 | -33.53% |
| Q4 2024 | 22.95% |
| Q3 2024 | -14.54% |
| Q2 2024 | 1.06% |
| Q1 2024 | -21.72% |
| Q4 2023 | 8.35% |
| Q3 2023 | 15.80% |
| Q2 2023 | -1.19% |
| Q1 2023 | -28.11% |
| Q4 2022 | 50.32% |
| Q3 2022 | -15.19% |
| Q2 2022 | 26.73% |
| Q1 2022 | 13.84% |
| Q4 2021 | -5.61% |
| Q3 2021 | 7.66% |
| Q2 2021 | 5.55% |
| Q1 2021 | 28.39% |
| Q4 2020 | 29.69% |
| Q3 2020 | 18.14% |
| Q2 2020 | 0.91% |
| Q1 2020 | 2.35% |
| Q4 2019 | 0.00% |